Skip to main content
F

FidoCure

One Health Company utilizes genomic testing and AI-driven precision medicine to identify targeted therapies for canine cancer, leveraging the largest proprietary cancer dataset from over 2,100 dogs. This approach addresses the high failure rate of traditional cancer treatments by providing veterinarians with data-driven insights to optimize treatment plans for individual dogs.

Palo Alto, United StatesFounded 2016223K+ followers
Updated 4 months ago

Funding

$15M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

+7
Funding rounds are not available yet.

Founders

Product

Problem

Traditional canine cancer treatments often have high failure rates due to their generalized approach, neglecting the unique genetic makeup of individual tumors. This can lead to ineffective therapies and suboptimal outcomes for dogs diagnosed with cancer.

Solution

One Health Company's FidoCure platform leverages genomic testing and AI-driven precision medicine to provide targeted therapies for canine cancer. By analyzing a large proprietary cancer dataset of genomic and clinical data from thousands of dogs, FidoCure identifies cancer-causing mutations specific to each dog's tumor. This enables veterinarians to develop personalized treatment plans that precisely target the cancer cells, potentially improving treatment efficacy and extending the dog's lifespan. The platform offers data-driven insights to optimize treatment strategies beyond standard chemotherapy and radiation.

Target Audience

The primary customers are veterinarians, particularly oncologists, who are seeking advanced diagnostic tools and personalized treatment options for canine cancer patients.

Features

  • Genomic sequencing of canine tumor samples to identify specific cancer-causing mutations
  • AI-driven analysis of genomic data to predict the effectiveness of targeted therapies
  • Access to a large proprietary database of canine cancer genomic and clinical data
  • Personalized treatment recommendations based on the individual dog's tumor profile
  • Support for a range of canine cancer types
  • Platform for veterinarians to manage cases and access treatment recommendations
This profile is AI-generated and may contain inaccuracies.